Fractyl Health's Promising Developments and Positive Outlook Justify Buy Rating

TipRanksJan 13 09:46 ET · Ratings

Fractyl Health's Promising Progress in Weight Management

TipRanksJan 13 08:11 ET

Express News | Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the Reveal-1 Cohort

ReutersJan 13 07:00 ET

Here's Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10

Yahoo FinanceJan 6 09:10 ET

Fractyl Health Reports Successful Delivery of RJVA-001 in Yucatan Pig Models, Paving the Way for First-in-Human Studies in 2025

Quiver QuantitativeDec 12, 2024 07:12 ET

Fractyl Health to Present New Preclinical Data From Its Rejuva Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

GlobeNewswireDec 9, 2024 07:00 ET